Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript - Thomson StreetEvents

Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript

Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript - Thomson StreetEvents
Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript
Published Sep 23, 2020
6 pages (2937 words) — Published Sep 23, 2020
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of BIIB.OQ conference call or presentation 23-Sep-20 5:00pm GMT

  
Brief Excerpt:

... of Neurology We're at the top of the hour, and I'm hoping that my video and sound is working. If something's not working, I hope the AAN folks will tell me. Welcome, everyone who's online. It's pretty exciting to be at the academy. It always is for the emerging science. I can't pretend that it's not more exciting to be sitting cheek to jowl in a room. But it's pretty exciting to be sitting here listening to the abstracts. There's a lot of very cool stuff. I'll remind you that these abstracts scored at the absolute top. This is what peers thought was really great science. So it's just going to be a fantastic collection of presentations. I'm Peter Goadsby. I'm a neurologist at UCLA and at King's in London. I don't have to read the usual sorts of things. You don't have to mute because everyone's turned off. You probably ought not smoke. But I guess it's your house, so whatever you want to do. We don't advise Amazon Shopping or any -- or -- and...

  
Report Type:

Transcript

Source:
Company:
Biogen Inc
Ticker
BIIB.OQ
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc Summary – 2020-11-30 – US$ 54.00 – Edited Brief of BIIB.OQ conference call or presentation 30-Nov-20 2:00pm GMT

Biogen Inc Conference Call to Discuss Collaboration with SAGE Therapeutics Inc Transcript – 2020-11-30 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 30-Nov-20 2:00pm GMT

Biogen Inc Aducanumab EMBARK study design and Q&A at CTAD 2020 Transcript – 2020-11-04 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 4-Nov-20 3:15pm GMT

Biogen Inc Q3 2020 Earnings Call Summary – 2020-10-21 – US$ 54.00 – Edited Brief of BIIB.OQ earnings conference call or presentation 21-Oct-20 12:00pm GMT

Biogen Inc Q3 2020 Earnings Call Transcript – 2020-10-21 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 21-Oct-20 12:00pm GMT

Biogen Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-14 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 14-Sep-20 2:30pm GMT

Biogen Inc Aducanumab Phase 3 Topline Results at AAIC (encore presentation and Q&A) Transcript – 2020-07-29 – US$ 54.00 – Edited Transcript of BIIB.OQ conference call or presentation 29-Jul-20 12:00pm GMT

Biogen Inc Q2 2020 Earnings Call Summary – 2020-07-22 – US$ 54.00 – Edited Brief of BIIB.OQ earnings conference call or presentation 22-Jul-20 12:00pm GMT

Biogen Inc Q2 2020 Earnings Call Transcript – 2020-07-22 – US$ 54.00 – Edited Transcript of BIIB.OQ earnings conference call or presentation 22-Jul-20 12:00pm GMT

Biogen Inc at Leerink CybeRx Series CNS Forum Transcript – 2020-06-23 – US$ 54.00 – Edited Transcript of BIIB.OQ presentation 23-Jun-20 4:30pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript" Sep 23, 2020. Alacra Store. May 24, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-Emerging-Science-Alzheimers-Migraine-ALS-CIDP-T13414437>
  
APA:
Thomson StreetEvents. (2020). Biogen Inc Emerging Science: Alzheimers, Migraine, ALS, CIDP Transcript Sep 23, 2020. New York, NY: Alacra Store. Retrieved May 24, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Biogen-Inc-Emerging-Science-Alzheimers-Migraine-ALS-CIDP-T13414437>
  
US$ 54.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.